Cipla gains USFDA approval for the generic version of Somatuline Depot (Lanreotide) injection EP News Bureau May 22, 2024 The new generic version to treat patients with GEP-NETs
Cipla receives USFDA nod to market Lanreotide injection in US market Press Trust of India Dec 20, 2021 The company said it has received final approval for Lanreotide Injection from the US Food and Drug Administration (FDA)